SCHEMBL8556598

SCHEMBL8556598

Cc1cc2c(cc1N(c1ccc3nsnc3c1C(=O)O)S(=O)(=O)c1ccsc1OC(=O)O)OCO2

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ EDNRA P25101 9/20 0.36
▸ EDNRB P24530 8/20 0.36
▸ PKM P14618 2/20 0.34
▸ ABCC3 O15438 1/20 0.34
▸ ABCC4 O15439 1/20 0.34
▸ ABCB11 O95342 1/20 0.34
▸ PDE4A P27815 1/20 0.34
▸ NPC1 O15118 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8557361 0.75 EDNRA (0.43) HSD17B10RAB9AEDNRAEDNRBABCC3
SCHEMBL8557046 0.68 EDNRA (0.42) HSD17B10RAB9AEDNRAEDNRBPKM
SCHEMBL8557591 0.67 EDNRA (0.44) HSD17B10RAB9AEDNRAEDNRBABCC3
SCHEMBL8627060 0.66 EDNRA (0.42) HSD17B10RAB9AEDNRAEDNRBABCC3
SCHEMBL8561556 0.65 EDNRA (0.44) HSD17B10RAB9AEDNRAEDNRBABCC3
SCHEMBL7949184 0.64 EDNRA (0.50) HSD17B10RAB9AEDNRAEDNRBABCC3
SCHEMBL7946892 0.60 EDNRA (0.49) HSD17B10RAB9AEDNRAEDNRBABCC3
SCHEMBL6314152 0.60 EDNRA (0.66) HSD17B10RAB9AEDNRAEDNRBABCC3
SCHEMBL8629983 0.60 EDNRA (0.48) RAB9AEDNRAEDNRBPKMABCC3
SCHEMBL8556595 0.60 EDNRA (0.49) HSD17B10RAB9AEDNRAEDNRBABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885219-A1 N-(2,1,3-BENZOTHIA(OXA)DIAZOLYL)-SULPHONAMIDES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GmbH (DE) 1998-12-23 — — EP disclosed
WO-1997030996-A1 N-(2,1,3-BENZOTHIA(OXA)DIAZOLYL)-SULPHONAMIDES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1997-08-28 — — WO disclosed
Send feedback